Characterization and Optimization

Characterization and Optimization

Identification and Validation

Information

We provide services to characterize and optimize your valuable monoclonal antibody. Specificity testing in various assays can be complemented with affinity ranking of antibody panels or epitope mapping and binning using BLI-based platforms. After hybridoma sequencing, we can clone, reformat, affinity mature, chimerize, or humanize your antibody before we produce the antibody recombinantly at a quality and quantity of your choice.
Link
https://www.immunoprecise.com/end-to-end-services/
ImmunoPrecise AntibodiesImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell SelectTM progressive, single-cell interrogation technology and the DeepDisplayTM custom phage libraries, as well as the AbthenaTM bispecific program. IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. ImmunoPrecise’s discovery and development are conducted in Utrecht and Oss, the Netherlands (U-Protein Express and IPA Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success.

Log in